ツムラの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/23 | 3,731 | 3,812 | 3,730 | 3,777 | -17 | -0.4% | 377,500 |
| 2024/04/22 | 3,795 | 3,824 | 3,745 | 3,794 | +17 | +0.5% | 361,700 |
| 2024/04/19 | 3,814 | 3,814 | 3,663 | 3,777 | -73 | -1.9% | 606,700 |
| 2024/04/18 | 3,878 | 3,899 | 3,843 | 3,850 | -30 | -0.8% | 325,000 |
| 2024/04/17 | 3,935 | 3,946 | 3,833 | 3,880 | -31 | -0.8% | 414,700 |
| 2024/04/16 | 3,899 | 3,931 | 3,872 | 3,911 | -2 | -0.1% | 303,400 |
| 2024/04/15 | 3,938 | 3,965 | 3,865 | 3,913 | -47 | -1.2% | 324,800 |
| 2024/04/12 | 3,930 | 3,978 | 3,921 | 3,960 | +2 | +0.1% | 252,400 |
| 2024/04/11 | 3,933 | 3,975 | 3,889 | 3,958 | +32 | +0.8% | 387,100 |
| 2024/04/10 | 3,895 | 3,952 | 3,878 | 3,926 | -14 | -0.4% | 313,600 |
| 2024/04/09 | 3,959 | 3,974 | 3,900 | 3,940 | +14 | +0.4% | 407,600 |
| 2024/04/08 | 3,812 | 3,930 | 3,780 | 3,926 | +115 | +3% | 453,300 |
| 2024/04/05 | 3,820 | 3,836 | 3,773 | 3,811 | -56 | -1.4% | 484,400 |
| 2024/04/04 | 3,810 | 3,903 | 3,779 | 3,867 | +96 | +2.5% | 433,600 |
| 2024/04/03 | 3,800 | 3,838 | 3,737 | 3,771 | +16 | +0.4% | 521,300 |
| 2024/04/02 | 3,801 | 3,825 | 3,721 | 3,755 | -79 | -2.1% | 609,100 |
| 2024/04/01 | 3,799 | 3,851 | 3,762 | 3,834 | +11 | +0.3% | 659,700 |
| 2024/03/29 | 3,760 | 3,892 | 3,701 | 3,823 | +60 | +1.6% | 468,700 |
| 2024/03/28 | 3,800 | 3,825 | 3,745 | 3,763 | -91 | -2.4% | 492,000 |
| 2024/03/27 | 3,888 | 3,890 | 3,814 | 3,854 | +7 | +0.2% | 446,600 |
| 2024/03/26 | 3,867 | 3,891 | 3,811 | 3,847 | -44 | -1.1% | 573,900 |
| 2024/03/25 | 4,049 | 4,082 | 3,891 | 3,891 | -109 | -2.7% | 861,600 |
| 2024/03/22 | 3,959 | 4,028 | 3,920 | 4,000 | +214 | +5.7% | 981,500 |
| 2024/03/21 | 3,860 | 3,938 | 3,744 | 3,786 | -4 | -0.1% | 648,600 |
| 2024/03/19 | 3,634 | 3,809 | 3,611 | 3,790 | +132 | +3.6% | 547,600 |
| 2024/03/18 | 3,671 | 3,689 | 3,633 | 3,658 | -12 | -0.3% | 328,700 |
| 2024/03/15 | 3,716 | 3,716 | 3,619 | 3,670 | -52 | -1.4% | 615,100 |
| 2024/03/14 | 3,725 | 3,731 | 3,653 | 3,722 | +33 | +0.9% | 420,200 |
| 2024/03/13 | 3,665 | 3,739 | 3,568 | 3,689 | +3 | +0.1% | 751,400 |
| 2024/03/12 | 3,662 | 3,708 | 3,599 | 3,686 | +2 | +0.1% | 597,700 |
| 2024/03/11 | 3,600 | 3,744 | 3,583 | 3,684 | +141 | +4% | 1,299,900 |
| 2024/03/08 | 3,658 | 3,707 | 3,484 | 3,543 | -185 | -5% | 1,763,100 |
| 2024/03/07 | 3,800 | 3,825 | 3,643 | 3,728 | +462 | +14.1% | 3,606,200 |
| 2024/03/06 | 3,016 | 3,266 | 3,003 | 3,266 | +500.5 | +18.1% | 2,756,800 |
| 2024/03/05 | 2,740.5 | 2,771.5 | 2,721 | 2,765.5 | +20.5 | +0.7% | 225,500 |
| 2024/03/04 | 2,762.5 | 2,769.5 | 2,742 | 2,745 | -16.5 | -0.6% | 229,200 |
| 2024/03/01 | 2,749 | 2,777.5 | 2,748.5 | 2,761.5 | +1.5 | +0.1% | 195,700 |
| 2024/02/29 | 2,750 | 2,773 | 2,738 | 2,760 | +7 | +0.3% | 334,600 |
| 2024/02/28 | 2,750 | 2,758.5 | 2,743.5 | 2,753 | -3 | -0.1% | 202,300 |
| 2024/02/27 | 2,742 | 2,772.5 | 2,742 | 2,756 | +12.5 | +0.5% | 140,900 |
| 2024/02/26 | 2,745 | 2,761 | 2,737 | 2,743.5 | +12.5 | +0.5% | 310,500 |
| 2024/02/22 | 2,737.5 | 2,749.5 | 2,707 | 2,731 | -19 | -0.7% | 345,400 |
| 2024/02/21 | 2,771 | 2,772.5 | 2,737 | 2,750 | -12 | -0.4% | 175,300 |
| 2024/02/20 | 2,772 | 2,780 | 2,750 | 2,762 | -4.5 | -0.2% | 199,500 |
| 2024/02/19 | 2,796 | 2,819.5 | 2,752 | 2,766.5 | -34.5 | -1.2% | 208,900 |
| 2024/02/16 | 2,796 | 2,829 | 2,787 | 2,801 | +49 | +1.8% | 320,600 |
| 2024/02/15 | 2,766 | 2,783.5 | 2,735 | 2,752 | -14.5 | -0.5% | 282,700 |
| 2024/02/14 | 2,838.5 | 2,841.5 | 2,765.5 | 2,766.5 | -64 | -2.3% | 283,800 |
| 2024/02/13 | 2,820 | 2,833.5 | 2,803 | 2,830.5 | +14.5 | +0.5% | 340,600 |
| 2024/02/09 | 2,850 | 2,850 | 2,809 | 2,816 | -67.5 | -2.3% | 279,500 |
251～
300
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
